Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Astrana Health Inc.

    NASDAQ: ASTH · Real-Time Price · USD
    24.76
    -0.30 (-1.20%)
    At close: Jun 05, 2025, 3:59 PM
    24.70
    -0.24%
    After-hours: Jun 05, 2025, 04:09 PM EDT

    Astrana Health Statistics

    Share Statistics

    Astrana Health has 49.93M shares outstanding. The number of shares has increased by 2.51% in one year.

    Shares Outstanding

    n/a
    		 49.93M

    Shares Change (YoY)

    n/a
    		 2.51%

    Shares Change (QoQ)

    n/a
    		 2.04%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 4

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 1.44M, so 3.12% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.44M

    Short % of Shares Out

    n/a
    		 3.12%

    Short % of Float

    n/a
    		 5.55%

    Short Ratio (days to cover)

    n/a
    		 4.4

    Valuation Ratios

    The PE ratio is 34.85 and the forward PE ratio is 17.3. Astrana Health's PEG ratio is -1.13.

    PE Ratio

    n/a
    		 34.85

    Forward PE

    n/a
    		 17.3

    PS Ratio

    n/a
    		 0.74

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 2.11

    P/FCF Ratio

    n/a
    		 34.04

    PEG Ratio

    n/a
    		 -1.13
    Financial Ratio History

    Enterprise Valuation

    Astrana Health has an Enterprise Value (EV) of 1.69B.

    EV / Sales

    n/a
    		 0.83

    EV / EBITDA

    n/a
    		 11.89

    EV / EBIT

    n/a
    		 32.32

    EV / FCF

    n/a
    		 38.19

    Financial Position

    The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.66.

    Current Ratio

    n/a
    		 2.87

    Quick Ratio

    n/a
    		 2.87

    Debt / Equity

    n/a
    		 0.66

    Debt / EBITDA

    n/a
    		 3.33

    Debt / FCF

    n/a
    		 10.68

    Interest Coverage

    n/a
    		 2.7

    Financial Efficiency

    Return on Equity is 6.05% and Return on Invested Capital is 4.81%.

    Return on Equity

    n/a
    		 6.05%

    Return on Assets

    n/a
    		 3.18%

    Return on Invested Capital

    n/a
    		 4.81%

    Revenue Per Employee

    n/a
    		 $1,070,810.53

    Profits Per Employee

    n/a
    		 $22,710

    Employee Count

    n/a
    		 1,900

    Asset Turnover

    n/a
    		 1.5

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 30.89M

    Effective Tax Rate

    n/a
    		 38.22%

    Stock Price Statistics

    The stock price has increased by -40.18% in the last 52 weeks. The beta is 0.86, so Astrana Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.86

    52-Week Price Change

    n/a
    		 -40.18%

    50-Day Moving Average

    n/a
    		 29.3

    200-Day Moving Average

    n/a
    		 39.61

    Relative Strength Index (RSI)

    n/a
    		 35.95

    Average Volume (20 Days)

    n/a
    		 303,687

    Income Statement

    In the last 12 months, Astrana Health had revenue of 2.03B and earned 43.15M in profits. Earnings per share was 0.9.

    Revenue

    n/a
    		 2.03B

    Gross Profit

    n/a
    		 271.39M

    Operating Income

    n/a
    		 89.35M

    Net Income

    n/a
    		 43.15M

    EBITDA

    n/a
    		 141.84M

    EBIT

    n/a
    		 113.92M

    Earnings Per Share (EPS)

    n/a
    		 0.9
    Full Income Statement

    Balance Sheet

    The company has 288.45M in cash and 471.84M in debt, giving a net cash position of -183.38M.

    Cash & Cash Equivalents

    n/a
    		 288.45M

    Total Debt

    n/a
    		 471.84M

    Net Cash

    n/a
    		 -183.38M

    Retained Earnings

    n/a
    		 286.28M

    Total Assets

    n/a
    		 868.29M

    Working Capital

    n/a
    		 -75.34M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 52.2M and capital expenditures -8.03M, giving a free cash flow of 44.17M.

    Operating Cash Flow

    n/a
    		 52.2M

    Capital Expenditures

    n/a
    		 -8.03M

    Free Cash Flow

    n/a
    		 44.17M

    FCF Per Share

    n/a
    		 0.93
    Full Cash Flow Statement

    Margins

    Gross margin is 13.34%, with operating and profit margins of 4.39% and 2.12%.

    Gross Margin

    n/a
    		 13.34%

    Operating Margin

    n/a
    		 4.39%

    Pretax Margin

    n/a
    		 3.97%

    Profit Margin

    n/a
    		 2.12%

    EBITDA Margin

    n/a
    		 6.97%

    EBIT Margin

    n/a
    		 4.39%

    FCF Margin

    n/a
    		 2.17%

    Dividends & Yields

    ASTH does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 2.87%

    FCF Yield

    n/a
    		 2.94%
    Dividend Details

    Analyst Forecast

    The average price target for ASTH is $50, which is 101.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $50

    Price Target Difference

    n/a
    		 101.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 17.44

    Graham Upside

    n/a
    		 -29.56%

    Stock Splits

    The last stock split was on Apr 27, 2015. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Apr 27, 2015

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 3.77

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist